However, MET was also described to be regulated by other mechanisms, such as the hypomethylation of its promoter in pancreatic cancer, and more than 30 microRNAs regulating MET expression, including miR-34a, downregulated in ESCC (30, –32). The gene discussed is MET; the disease is pancreatic neoplasm.